Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-06-13 | New | $2,228,043 | $2,228,043 | Equity Only | 06b | SEC link |
| 2020-08-28 | New | $21,772,000 | $21,772,000 | Equity Only | 06b | SEC link |
| 2020-08-27 | New | $21,772,000 | $21,772,000 | Equity Only | 06b | SEC link |
| 2016-05-10 | New | $5,600,000 | $5,600,000 | Equity Only | 06b | SEC link |
| 2013-03-07 | Amended | $10,500,000 | $2,571,450 | Equity Only | 06 | SEC link |
| 2013-02-14 | Amended | $7,928,550 | $1,041,100 | Equity Only | 06 | SEC link |
| 2013-02-08 | New | $6,887,450 | $6,887,450 | Equity Only | 06 | SEC link |
| 2013-02-08 | Amended | $6,887,450 | $0 | Equity Only | 06 | SEC link |
| Name | Role |
|---|---|
| Jeffrey Bacha | Director, Executive |
| John K Bell | Director |
| James Bianco | Director, Executive |
| Dennis Brown | Executive |
| Lynda Cranston | Director |
| Dan Dearborn | Executive |
| William Garner | Director |
| Lisa Guise | Director |
| Robert Hoffman | Director |
| Laura Johnson | Director |
| John Liatos | Director, Executive |
| Alan List | Director |
| James Manuso | Director |
| Erich Mohr | Director |
| Keith Murphy | Director |
| George Ng | Director |
| Scott Praill | Executive |
| Steven Rychnovsky | Executive |
| Craig Tendler | Director |
| Robert Toth | Director |
| Saiid Zarrabian | Director, Executive |